APA

Clemons M., Dranitsaris G., Ooi W. & Cole D. E. C. (20080520). A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy. : Breast cancer research and treatment.

Chicago

Clemons Mark, Dranitsaris George, Ooi Wei and Cole David E C. 20080520. A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy. : Breast cancer research and treatment.

Harvard

Clemons M., Dranitsaris G., Ooi W. and Cole D. E. C. (20080520). A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy. : Breast cancer research and treatment.

MLA

Clemons Mark, Dranitsaris George, Ooi Wei and Cole David E C. A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy. : Breast cancer research and treatment. 20080520.